These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

158 related articles for article (PubMed ID: 37414503)

  • 1. Medicinal Cannabis Guidance and Resources for Health Professionals to Inform Clinical Decision Making.
    Graham M; Renaud E; Lucas CJ; Schneider J; Martin JH
    Clin Ther; 2023 Jun; 45(6):527-534. PubMed ID: 37414503
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Differences in prescribed medicinal cannabis use by cannabinoid product composition: Findings from the cannabis as medicine survey 2020 (CAMS-20) Australia-wide study.
    Trevitt BT; Bailey S; Mills L; Arkell TR; Suraev A; McGregor IS; Lintzeris N
    PLoS One; 2024; 19(2):e0297092. PubMed ID: 38354169
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Medicinal cannabis for patients with chronic non-cancer pain: analysis of safety and concomitant medications.
    Schubert EA; Alffenaar JC; Johnstone MT; Barlow JW; Wheate NJ
    Int J Pharm Pract; 2023 Mar; 31(1):70-79. PubMed ID: 36445409
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Comprehensive Review of Medicinal Marijuana, Cannabinoids, and Therapeutic Implications in Medicine and Headache: What a Long Strange Trip It's Been ….
    Baron EP
    Headache; 2015 Jun; 55(6):885-916. PubMed ID: 26015168
    [TBL] [Abstract][Full Text] [Related]  

  • 5. A cross-sectional survey exploring the knowledge, experiences and attitudes of Australian pharmacists toward medicinal cannabis.
    Bawa Z; Saini B; McCartney D; Bedoya-Pérez M; McLachlan AJ; McGregor IS
    Int J Clin Pharm; 2023 Apr; 45(2):375-386. PubMed ID: 36446995
    [TBL] [Abstract][Full Text] [Related]  

  • 6. The future of Cochrane Neonatal.
    Soll RF; Ovelman C; McGuire W
    Early Hum Dev; 2020 Nov; 150():105191. PubMed ID: 33036834
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Barriers and facilitators to prescribing medicinal cannabis in New Zealand.
    Withanarachchie V; Rychert M; Wilkins C
    J Prim Health Care; 2023 Jun; 15(2):135-146. PubMed ID: 37390030
    [TBL] [Abstract][Full Text] [Related]  

  • 8. UK Medical Cannabis Registry: an analysis of clinical outcomes of medicinal cannabis therapy for generalized anxiety disorder.
    Ergisi M; Erridge S; Harris M; Kawka M; Nimalan D; Salazar O; Loupasaki K; Ali R; Holvey C; Coomber R; Platt M; Rucker JJ; Sodergren MH
    Expert Rev Clin Pharmacol; 2022 Apr; 15(4):487-495. PubMed ID: 34937473
    [TBL] [Abstract][Full Text] [Related]  

  • 9. A primer on medicinal cannabis safety and potential adverse effects.
    Arnold JC
    Aust J Gen Pract; 2021 Jun; 50(6):345-350. PubMed ID: 34059837
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Medicinal cannabis for the treatment of anxiety disorders.
    Berger M; Amminger GP; McGregor IS
    Aust J Gen Pract; 2022 Aug; 51(8):586-592. PubMed ID: 35908759
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Using Therapeutic Drug Monitoring and Pharmacovigilance to Overcome Some of the Challenges of Developing Medicinal Cannabis from Botanical Origins.
    Dryburgh LM; Martin JH
    Ther Drug Monit; 2020 Feb; 42(1):98-101. PubMed ID: 31479044
    [TBL] [Abstract][Full Text] [Related]  

  • 12. The Rise and Rise of Medicinal Cannabis, What Now? Medicinal Cannabis Prescribing in Australia 2017-2022.
    Hallinan CM; Bonomo YA
    Int J Environ Res Public Health; 2022 Aug; 19(16):. PubMed ID: 36011488
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Medical use of cannabis products: Lessons to be learned from Israel and Canada.
    Ablin J; Ste-Marie PA; Schäfer M; Häuser W; Fitzcharles MA
    Schmerz; 2016 Feb; 30(1):3-13. PubMed ID: 26767992
    [TBL] [Abstract][Full Text] [Related]  

  • 14. "Is medical cannabis safe for my patients?" A practical review of cannabis safety considerations.
    MacCallum CA; Lo LA; Boivin M
    Eur J Intern Med; 2021 Jul; 89():10-18. PubMed ID: 34083092
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Cannabis for the treatment of ulcerative colitis.
    Kafil TS; Nguyen TM; MacDonald JK; Chande N
    Cochrane Database Syst Rev; 2018 Nov; 11(11):CD012954. PubMed ID: 30406638
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Medicinal cannabis in Latin America: History, current state of regulation, and the role of the pharmacist in a new clinical experience with cannabidiol oil.
    Cáceres Guido P; Riva N; Calle G; Dell'Orso M; Gatto M; Sberna N; Schaiquevich P
    J Am Pharm Assoc (2003); 2020; 60(1):212-215. PubMed ID: 31706799
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Medicinal cannabis for psychiatric disorders: a clinically-focused systematic review.
    Sarris J; Sinclair J; Karamacoska D; Davidson M; Firth J
    BMC Psychiatry; 2020 Jan; 20(1):24. PubMed ID: 31948424
    [TBL] [Abstract][Full Text] [Related]  

  • 18. A large Australian longitudinal cohort registry demonstrates sustained safety and efficacy of oral medicinal cannabis for at least two years.
    Vickery AW; Roth S; Ernenwein T; Kennedy J; Washer P
    PLoS One; 2022; 17(11):e0272241. PubMed ID: 36399463
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Medicinal cannabis in the treatment of chronic pain.
    Henderson LA; Kotsirilos V; Cairns EA; Ramachandran A; Peck CC; McGregor IS
    Aust J Gen Pract; 2021 Oct; 50(10):724-732. PubMed ID: 34590094
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Assessment of clinical outcomes of medicinal cannabis therapy for depression: analysis from the UK Medical Cannabis Registry.
    Mangoo S; Erridge S; Holvey C; Coomber R; Barros DAR; Bhoskar U; Mwimba G; Praveen K; Symeon C; Sachdeva-Mohan S; Rucker JJ; Sodergren MH
    Expert Rev Neurother; 2022; 22(11-12):995-1008. PubMed ID: 36573268
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.